SURAKSHA

Suraksha Diagnostic Limited

Suraksha Diagnostic Limited (SURAKSHA) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider

surakshanet.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹306.70
Market cap
1,596 Cr
Stock P/E
44.6
P/B
6.54
ROE (FY26)
13.2%
ROCE (FY26)
23.3%
Operating margin (FY26)
17.4%
Debt / equity (FY26)
0.0071
OCF / EBITDA (FY26)
85.8%
OCF / EBITDA (3Y)
83.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Suraksha runs a network of diagnostic centres in West Bengal and nearby eastern states, selling pathology and radiology tests, genomic tests and doctor consultations to patients, referring doctors and corporate and public-sector clients.

Company snapshot

7thBy market cap

Ranked among 10 companies in Healthcare Service Provider.

What we see

Positives
  • ✓Debt-to-equity of 0.01x — the company is largely funded by its own money, not borrowed funds.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales67 Cr60 Cr65 Cr73 Cr79 Cr78 Cr81 Cr88 Cr
Operating expenses (approx.)44 Cr41 Cr46 Cr49 Cr55 Cr55 Cr57 Cr57 Cr
EBITDA23 Cr18 Cr19 Cr24 Cr24 Cr23 Cr24 Cr30 Cr
OPM %34.7%30.7%29.5%32.7%30.6%29.8%29.9%34.7%
Other income1 Cr0.60 Cr0.82 Cr0.91 Cr0.85 Cr0.62 Cr0.79 Cr1 Cr
Interest2 Cr2 Cr2 Cr3 Cr3 Cr3 Cr4 Cr4 Cr
Depreciation9 Cr9 Cr9 Cr9 Cr10 Cr11 Cr11 Cr11 Cr
Profit before tax14 Cr8 Cr9 Cr12 Cr12 Cr10 Cr10 Cr17 Cr
Tax %25.5%25.6%22.2%26.4%26.7%28.0%38.3%22.3%
Net profit10 Cr6 Cr7 Cr9 Cr9 Cr7 Cr6 Cr13 Cr
EPS (₹)₹1.94₹1.18₹1.42₹1.80₹1.73₹1.44₹1.21₹2.50

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales223 Cr190 Cr219 Cr252 Cr310 CrSign in free for the trailing twelve months
Operating expenses (approx.)161 Cr146 Cr149 Cr171 Cr215 CrSign in free for the trailing twelve months
EBITDA63 Cr44 Cr70 Cr81 Cr95 CrSign in free for the trailing twelve months
OPM %28.1%23.1%32.0%32.2%30.7%Sign in free for the trailing twelve months
Other income3 Cr4 Cr4 Cr4 Cr3 CrSign in free for the trailing twelve months
Interest9 Cr9 Cr9 Cr8 Cr13 CrSign in free for the trailing twelve months
Depreciation28 Cr32 Cr33 Cr35 Cr41 CrSign in free for the trailing twelve months
Profit before tax28 Cr7 Cr31 Cr41 Cr45 CrSign in free for the trailing twelve months
Tax %25.7%10.1%26.5%25.2%29.5%Sign in free for the trailing twelve months
Net profit21 Cr6 Cr23 Cr31 Cr31 CrSign in free for the trailing twelve months
EPS (₹)₹3.91₹1.22₹4.43₹5.97₹6.18Sign in free for the trailing twelve months
Dividend payout %———0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital7 Cr7 Cr7 Cr10 Cr10 Cr
Reserves139 Cr149 Cr173 Cr201 Cr234 Cr
Borrowings19 Cr14 Cr9 Cr6 Cr2 Cr
Other liabilities111 Cr112 Cr112 Cr117 Cr203 Cr
Total liabilities276 Cr281 Cr300 Cr334 Cr448 Cr
Fixed assets (net)118 Cr113 Cr135 Cr147 Cr194 Cr
CWIP1 Cr2 Cr1 Cr10 Cr35 Cr
Investments———1 Cr0 Cr
Inventories6 Cr6 Cr7 Cr8 Cr8 Cr
Trade receivables7 Cr5 Cr9 Cr14 Cr23 Cr
Cash & bank3 Cr2 Cr3 Cr2 Cr3 Cr
Other assets141 Cr153 Cr146 Cr151 Cr185 Cr
Total assets276 Cr281 Cr300 Cr334 Cr448 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity58 Cr44 Cr60 Cr63 Cr82 Cr
Cash from investing-43 Cr-21 Cr-35 Cr-40 Cr-52 Cr
Cash from financing-14 Cr-24 Cr-25 Cr-24 Cr-29 Cr
Net cash flow0.26 Cr-1 Cr0.36 Cr-0.27 Cr0.97 Cr
Free cash flow (OCF − Capex)39 Cr32 Cr18 Cr21 Cr14 Cr

Ratios

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %22.4%9.3%21.4%23.0%23.3%
ROE %14.3%4.2%13.2%15.1%13.2%
Debtor days119152027
Inventory days3882899981
Days payable83186193168208
Cash conversion cycle-34-96-89-49-100
OCF / EBITDA %92.3%100.4%86.3%78.0%85.8%
OCF / EBITDA % (3 years)——91.9%86.0%83.4%
Debt / equity0.130.090.050.030.0071
Current ratio1.641.771.841.101.05
Net debt / EBITDA0.250.270.090.04-0.02